Delivery Order SPE2DR25D3013-SPE2DR26F6U2M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,589.55 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 12, 2025, with completion expected by November 13, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $7,387.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Arimidex 1 mg tablets, with a completion date of December 9, 2025. This is a non-set-aside contract issued competitively to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader contract vehicle with the Defense Logistics Agency. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,616.17 by the Defense Logistics Agency on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by November 26, 2025. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a $108.8K delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract reflects firm fixed pricing and carries an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 units) under a firm fixed-price contract valued at $49,291.72. The order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,407.96 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Arimidex 1 mg tablets in a quantity of 30 tablets. This is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, to be performed at the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6U2MDelivery Order
The Defense Logistics Agency awarded a $12,043.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-tablet bottles of Arimidex 1 mg tablets, with an ultimate completion date of December 10, 2025. This non-set-aside award was issued competitively and represents a pharmaceutical supply delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, medical supplies, and healthcare commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The award aligns with the DLA Troop Support's strategic pharmaceutical procurement approach, which includes planning for multiple regional contracts under the Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 12/8/25 |